A Phase II study of isatuximab (SAR650984) (NSC-795145) for patients with previously treated al amyloidosis (SWOG S1702; NCT#03499808) Meeting Abstract
| Authors: | Parker, T. L.; Rosenthal, A.; Sanchorawala, V.; Landau, H. J.; Campagnaro, E.; Kapoor, P.; Neparidze, N.; Hagen, P.; Sarosiek, S.; Scott, E. C.; Hoering, A.; Durie, B. G. M.; Usmani, S. Z.; Orlowski, R. Z. |
| Abstract Title: | A Phase II study of isatuximab (SAR650984) (NSC-795145) for patients with previously treated al amyloidosis (SWOG S1702; NCT#03499808) |
| Meeting Title: | 62nd Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 136 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2020 Dec 5-8 |
| Meeting Location: | Virtual |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2020-11-05 |
| Language: | English |
| ACCESSION: | WOS:000607547202204 |
| DOI: | 10.1182/blood-2020-143180 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 20 -- Source: Wos |
